A Study of the Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (MT-3724NHL001)
A Study of the Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (MT-3724NHL001)
Trial Category:
Lymphoma
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
